ASAH1 and breast carcinoma: The effect of AC inhibitors (DM102 and NOE) in combination with C6-Cer (C6-cer), a cell-permeable analog of Cer, has been studied in three different breast cancer cell lines MDA-MB-231, MCF-7, and BT-474 cells.